mr. flanagan? >> mr. chairman, can i answer?i don't know how the rules work. >> please, yes. >> so two things. first is, if a submission comes in the door and it's for a product for which there isn't generic competition or for which there is a drug shortage, we consider those to be priorities, and he expedite their review. >> that's interesting, because i have a letter that basically is from dr. woodcock, that would suggest that shortage is not part of your decisionmaking process. so you're saying her letter is wrong? >> i need to see the letter. we for sure consider -- >> we'll follow up on it. i'm way beyond -- >> the gentleman's time is expired. we do expect votes on the floor soon. we'll recognize the gentlewoman from new mexico for five minutes. >> thank you, mr. chairman. i really appreciate you holding this hearing. and quite frankly, i share my colleague's you'll rage. i think outrage is actually too soft a word, given what we've heard today, what we knew before today, what we still don't know after today, but what's rea

mr. flanagan regarding the generic backlog when mr. meadows was talking about. can you provide clarity as to how the fda is prioritizing applications to expedite the review process? >> yes, sir. there is a policy that's available online, you can find it on the website basically certain categories of submissions like first generic second essentially open the market to competition drugs and to mitigate shortage, hiv drugs and a couple of other specific categories. >> so it's based on disease, disease, the prioritizing, so what you're saying? >> summer based on the disease, the shortages just based on whether there's a shortage out there and providers. first generic the pens on whether the market has already been opened up. >> there's no real standard policy. >> all there is a standard alliance were review cycles? >> is hard to answer that question because it depends on how long it takes the applicant to respond back to. >> okay targeted action dates are assigned and yet they're aspirational, noncommittal, what's the point of having a targeted action action date if

mr. keith flanagan and we'll swear him and at the same time. mr. howard schiller is the interim chief executive officer of value pharmaceuticals, we appreciate you being here. miss nancy -- at turing pharmaceuticals and mr. martin school rally. we appreciate you being here all witnesses are to be sworn before they testify. we will also be swearing and mr. flanagan. if if you would please all rise and raise your right hand. do solemnly swear that the testimony you are about to give will be the truth, the whole truth, nothing but the truth? >> thank you. let the record reflect that all answered in the affirmative. in order to allow time we appreciate you limiting your oral statements to five minutes. mr. merritt you are now recognize for five minutes. >> thank you. i am mark merritt, president ceo of of the pharmaceutical care management association, the group representing the benefit managers. or pbm's. we administered drug benefits for more than 260 million americans. over the next decade pbn's are projected to save 654 billion or up to 30% on drug

mr. flanagan regarding generic backlog what mr. meadows was talking about the could you provide more clarity as to the fda has prioritized applications to expedite the process? >> yes, sir. so there's a policy that's available online, like on the website. and basically certain categories of submissions, like first generics, that can potentially open the market to competition, drugs that can mitigate shortage, pepfar or hiv drugs and a couple other specific categories to speak so it's based on the disease, the prioritizing of is that what you're saying? >> the pepfar ones are based on the disease. the shortages is just based on whether kind of whether there's a shortage out there in providers. and first generics depends on whether the market has already, you know, opened up to generics. >> so there's no real standard policy? >> there's a standard policy. >> how long is for review cycles? >> guitar to answer the question because it depends on how long it takes the applicant to respond back to us. >> okay. the targeted action dates, t

mr. keith flanagan. the interim chief executive officer of pharmaceuticals international, thank you for being here. the chief commercial officer returning pharmaceutical and we have mr. martin the chief executive officer we appreciate you being here pursuant to the committee roles all witnesses are to be sworn in before they testify and we will also be swearing in mr. flanagin if you would all rise and raise your right hand. [applause] do you solemnly swear or affirm the testimony you are about to get will be the truth, the whole truth and nothing but the truth? >> what the record reflect the witnesses all answered in the affirmative. to allow time for discussion we would appreciate limiting your statements to five minutes. you are now recognized. >> thank you esther chair and other members of the committee. i'm the president and ceo of the management association representing america's pharmacy benefit managers. pdm is administered for more than 260 million americans with coverage to employers, unions, st

mr. flanagan >> mechanic system another graph looking at go where and how we plan to distribute the budget so the firstgraphy is showing we're spendinglism thirty percent of our budget on seismic upgrades and the rest is kind of the history of the mechanic, electrical systems and the iceland gets a little bit and plumbing a little bit we don't have much budget to renovate, upgrade the sites but we have a small bit of sites upgrades and one of the stations so the next two slides is actually - we with this assessments from the professional team and also with the budget we've identified 10 projects that will execute the next 5 years and there's going to be si5 projects and upgrades and grants of the projects will pass a service component to it with the system upgrades a so currently 3 projects that are underway of which two or ada upgrades one under construction and the other at the end of the design and about to go out to permit and construction is slate for later this year and so i can - maybe we can look at the schedule this is a 5 year look ahead of our plan started in 2015 and mr. will c

mr. flanagan >> mechanic system another graph looking at go where and how we plan to distribute the budget so the firstgraphy is showing we're spendinglism thirty percent of our budget on seismic upgrades and the rest is kind of the history of the mechanic, electrical systems and the iceland gets a little bit and plumbing a little bit we don't have much budget to renovate, upgrade the sites but we have a small bit of sites upgrades and one of the stations so the next two slides is actually - we with this assessments from the professional team and also with the budget we've identified 10 projects that will execute the next 5 years and there's going to be si5 projects and upgrades and grants of the projects will pass a service component to it with the system upgrades a so currently 3 projects that are underway of which two or ada upgrades one under construction and the other at the end of the design and about to go out to permit and construction is slate for later this year and so i can - maybe we can look at the schedule this is a 5 year look ahead of our plan started in 2015 and mr. will c

she will remembbe replaced by m keith flanagan. mr. howard shiller valeant pharmaceuticals international. appreciate you being here. nancy red slaf, and mr. martin shkreli. all witnesses are to be sworn before you testify. if you would rise and raise your right hand. do you column emisolemnly swear the truestimony you are about t be give will be the truth and nothing but the truth. your statement will be limited to five minutes. >> thank you, mr. chairman. i'm mark merit, president and ceo. >> martin shkreli, if he gives my statement will come last. we'll take a break here. look at the futures. we haven't gotten to a lot of names. ralph lauren, dunkin and kohl's. here at td ameritrade, they work hard. wow, that was random. random? no. it's all about understanding patterns. like the mail guy at 3:12pm every day or jerry getting dumped every third tuesday. jerry: every third tuesday. we have pattern recognition technology on any chart plus over 300 customizable studies to help you anticipate potential price movement. there's no way to pr

flanagan: i supported governor k-6. i came out early. i supported him in june. voters will vote the way they i think with mr. trump, he is saying things that people are thinking. i do not think the same way he does. what a block of people -- but a block of people say that he is the one saying what they' re thinking. if he is the vote-getter, he is the vote-getter, just like if it is mrs. clinton or senator sanders. the other thing though is we cannot tell people one way or another how to vote. josh: leave it to the voters, right? rep. flanagan: that' s how we do it. and i' m glad that my guy finish second in new hampshire. can i put in a plug -- flanaganfornh.com is the website. if you have any questions or inquiries. josh: or you want to donate. rep. flanagan: or donate. press the red button. josh: welcome back. this week, and intense political battle started after the passing of supreme court justice antonin scalia appear. in public and saying this is an election year, no one should be nominated, the president saying it is his duty to nominate someone. let' started. guest: i was, to be honest. whether you

flanagan. back to lee and frank. >>> former president bill clinton and daughter chelsea are hitting the road. mr. clinton is hosting a get out the vote event in cincinnati on friday. chelsea will be in cleveland on monday encouraging supporters to vote in ohio's primary. >>> ohio voters head to the polls march 15th but the deadline to register to vote is next week. if you moved, got married, or have until next tuesday to get a new registration form mailed to you from your local board of elections. >>> new developments now on 5. a john carroll university employee has been indicted on grand theft charges in connection with a jewel heist. the 36-year-old is accused of stealing seven sapphires from the cleveland museum of natural history. he pleaded not guilty. they were worth more than $80,000. they have not been recovered. >>> environmental officials just issued another violation to sebring in connection with the village's contaminated tap water. the epa says sebring officials fade to communicate recent water test results to homeowners who requested sampling. nearly 700 water samples have been subm